The younger generation across the globe, especially in Western countries, is facing rapidly increasing rates of infertility. This includes Canada, the U.S., Finland, Russia, the Netherlands, Norway, and Denmark, etc. Something is robbing young men and women of their capacity to procreate.
A study, published in December 2018, in the Journal of Toxicology and Environmental Health is a good place to start investigating this catastrophe. The study compared those who received the human papilloma virus (HPV) vaccine (supposedly to protect against cervical cancer) with those who didn’t – and the results are chilling. No one in public health, medicine or mainstream media, which are tangled up in the money-making machine of the vaccine’s manufacturers, dares to publicly question the “safe and effective” mantra that these drug manufacturers, Merck and GSK Pharmaceuticals, are proclaiming. This “blockbuster” drug has earned billions of dollars for these manufacturers.
Intense advertising and promotion of the HPV vaccine have made the vaccination available in every doctor’s office in Canada.
In 2005, the HPV vaccine was approved by the U.S. Food and Drug Administration for use in the U.S., and was approved by Health Canada in 2007.
The researchers, whose study was published in the Journal of Toxicology, in 2018, had examined eight million women residing in the United States in the years between 2007 and 2014, who were between the ages of 25 and 29. The results indicate that 60% of women who did not receive the HPV vaccine had become pregnant at least once, compared to just 35% of women who had had the HPV injection. For married women, 75% who did not receive the injection were found to conceive, while only 50% who received the vaccine had ever been pregnant.
Also, according to this study, some vaccine recipients have reported, “primary ovarian failure” – girls in their teens and young women in their 20s experiencing menopause. HPV injections have also been connected to a high number of adverse medical problems, 45,217 from its introduction in 2007 to May, 2016.
To be sure, many environmental factors could be affecting female fertility. Plunging male fertility is such a factor. Male sperm counts have nosedived in recent decades – scientists published data last year showing that, globally, they have dropped 50% in just the past 40 years. No one knows why – perhaps from unidentified environmental hazards. It is significant, however, that a study published in the Journal of Human Reproduction (October 2019) found that men producing no or little sperm, with no defined cause of infertility, were infected with the sexually transmitted disease, chlamydia in their testicular tissue. Chlamydia in men has not been as widely studied as it has been in women, despite similar infection rates. It is important to determine if this is the cause of the failure of sperm to develop in the testes. However, this still doesn’t entirely explain female infertility, which could be caused by the HPV vaccine.
So, why is the HPV vaccine so heavily marketed to begin with? Why widely distribute a vaccine for a disease that afflicts less than 0.3% of people in their lifetime?
Given the world’s infertility crisis, questions about the long-term impact of the HPV vaccine on female fertility are justified.